Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

16 results
  1. NLM Digital Collections - Principles of premarket pathways for combination products : guidance for industry and FDA ... 
    Publication: Silver Spring, MD : Center for Drug Evaluation and Research, January 2022
    ... device and biological products, or biological and drug products (a co-packaged combination product, such as a surgical or first-aid kit ...
  2. NLM Digital Collections - Assessing user fees under the Prescription Drug User Fee Amendments of 2017 
    Publication: Silver Spring, MD : Center for Drug Evaluation and Research, May 2018
    ... for industry User Fee Waivers for FDC and Co-Packaged HIV Drugs for PEPFAR. Companies submitting combination products under 21 CFR 3.2(e) should see ... Waivers, Reductions, and Refunds for Drug and Biological Products 59 • ... Waivers for FDC and Co-Packaged HIV Drugs for PEPFAR 60 The following manuals ...
  3. NLM Digital Collections - Chemistry, manufacturing, and controls changes to an approved application : certain ... 
    Publication: Silver Spring, MD : Center for Drug Evaluation and Research, June 2021
    ... Addition of a strength. Change in the diluent co-packaged with the product (e.g., new manufacturer, new location, new filling ...
  4. NLM Digital Collections - M4 organization of the Common Technical Document for the Registration of Pharmaceuticals for .... 
    Publication: Silver Spring, MD : Center for Drug Evaluation and Research, October 2017
    ... containing multiple drug substances or for different drug products that are co- packaged. An international non-proprietary name (INN) is recommended ...
  5. NLM Digital Collections - FDA oversight 
    Publication: [Toronto, Ontario] : Thomson Reuters, 21-December-2020
    ... FDA approved Oriahnn (an estrogen and progestin combination product consisting of elagolix, estradiol and norethindrone acetate) capsules, co-packaged for oral use, for the management of heavy ...
  6. NLM Digital Collections - Unique device identification : convenience kits : guidance for industry and Food and Drug ... 
    Publication: Silver Spring, MD : Center for Devices and Radiological Health, April 26, 2019
    ... requirements.12 10 Many first aid kits comprise co-packaged drug and device components and are therefore combination products (see 21 CFR 3.2(e)(2)). As ...
  7. NLM Digital Collections - Prescription Drug User Fee Act waivers, reductions, and refunds for drug and biological ... 
    Publication: Silver Spring, MD : Center for Drug Evaluation and Research, October 2019
    ... for industry, User Fee Waivers for FDC and Co-Packaged HIV Drugs for PEPFAR; (2) for applicants submitting combination products under 21 Code of Federal Regulations 3.2( ...
  8. NLM Digital Collections - Liposome drug products : chemistry, manufacturing, and controls : human pharmacokinetics and .... 
    Publication: Silver Spring, MD : Center for Drug Evaluation and Research, April 2018
    ... is labeled for use after reconstitution with a co-packaged or other specified diluent, or is labeled for use after mixing it with other approved drug products (e.g., large volume injectable solutions), supporting stability ...
  9. NLM Digital Collections - How to prepare a pre-request for designation (pre-RFD) 
    Publication: [Silver Spring, Maryland] : Office of Combination Products, Office of the Commissioner, February 2018
    ... to make a single entity or will be co-packaged? 6. A listing of all components/ingredients, including the amount and reasoning for including each component/ingredient, in the product. If the product contains a solution/liquid/gel/ ...
  10. NLM Digital Collections - Assessing user fees under the prescription drug user fee amendments of 2017 
    Publication: Silver Spring, MD : Center for Drug Evaluation and Research, November 2020
    ... for industry User Fee Waivers for FDC and Co-Packaged HIV Drugs for PEPFAR. Companies submitting combination products under 21 CFR 3.2(e) should see ...
previous · 1 · 2 · next